Life-Threatening Reaction with Topical 5-Fluorouracil.
Patrick KishiCynthia J PricePublished in: Drug safety - case reports (2018)
A 67-year-old man developed a suspected adverse drug reaction during treatment with topical 5-fluorouracil (5-FU) for multiple actinic keratosis of the face, neck, and forearms. The man received topical 5-FU at a dosage of 0.5% for the actinic keratoses. After 1 week, he developed extreme lethargy, fatigue, fever, and mouth erosions. Several days later, and after discontinuation of 5-FU, painful mucositis and systemic side effects occurred, meeting criteria for hospitalization because of dehydration and a 6.8 kg weight loss. Hematology/oncology was consulted, and a possible systemic 5-FU reaction, similar to reactions to intravenous chemotherapy seen with a dihydropyrimidine dehydrogenase deficiency was suggested. The patient was not taking any concurrent medications, and he refused dihydropyrimidine dehydrogenase deficiency testing.
Keyphrases
- adverse drug
- weight loss
- wound healing
- bariatric surgery
- case report
- high dose
- pulmonary embolism
- radiation induced
- emergency department
- replacement therapy
- climate change
- electron transfer
- roux en y gastric bypass
- radiation therapy
- type diabetes
- squamous cell carcinoma
- electronic health record
- clinical trial
- gastric bypass
- adipose tissue
- sleep quality
- chemotherapy induced
- study protocol
- skeletal muscle
- weight gain
- obese patients